Cargando…
Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Direct oral anticoagulants (DOACs) represent an attractive alternative to low-molecular-weight heparins (LMWHs) for the long-term treatment of cancer-associated thrombosis (CT) since they avoid the burden of daily injections. Analyses in subgroups of cancer patients from large randomized trials sugg...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Georg Thieme Verlag KG
2019
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746618/ https://www.ncbi.nlm.nih.gov/pubmed/31535076 http://dx.doi.org/10.1055/s-0039-1696659 |